The latest annual report from Professor Dame Sally Davies, the Chief Medical Officer (CMO) for England unveils a “genomic dream” vision, whereby whole genome screening (WGS) might soon become standard practice in the NHS, much like blood tests and biopsies. Ideally, the service should be centralised, with a national network to ensure equal access to testing across the country.
Professor Dame Sally Davies’s eighth independent annual report examines the state of genomic services in the NHS in England, and explores the potential for genomics to improve health / prevent ill-health. It covers:
- Diagnosis of rare diseases.
- The use of genomics in personalised prevention.
This report investigates existing gaps in:
- Public engagement, and issues of potential concern such as privacy and data protection.
- Organisation of genomic research.
- Provision of genomic services.
“A new National Genomics Board would be set up, chaired by a minister, to oversee the expansion and development of genomic services”.
Roberts, M. (2017). Chief medical officer calls for gene testing revolution. London: BBC Health News, July 4th 2017.
This relates to:
Annual report of the Chief Medical Officer 2016: Generation Genome. London: Department of Health, July 2017.
Possibly of interest, the NIHR BioResource Rare Diseases and NIHR Rare Diseases Translational Research Collaboration (RD-TRC) involve fourteen themes:
- Dementia and Neurodegenerative Disease.
- Eye disease.
- Gastrointestinal disease.
- Non-malignant Haematology.
- Immunological disorders.
- Metabolism and Endocrinology.
- Musculoskeletal disease.
- Neuromuscular disorders.
- Respiratory disease.
- Skin disease.
- Renal disease.